|
US4642316A
(en)
*
|
1985-05-20 |
1987-02-10 |
Warner-Lambert Company |
Parenteral phenytoin preparations
|
|
US6071923A
(en)
*
|
1994-09-16 |
2000-06-06 |
Bar-Ilan University |
Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
|
|
US20020025921A1
(en)
*
|
1999-07-26 |
2002-02-28 |
Petito George D. |
Composition and method for growing, protecting, and healing tissues and cells
|
|
BR9914779A
(pt)
*
|
1998-10-13 |
2001-07-03 |
Fujisawa Pharmaceutical Co |
Composto wf27082, processo para sua produção, composição farmacêutica contendo o mesmo, cepa de fundos pertencente ao gênero acremonium, composto tendo atividade inibidora de desacetilase de histona, processo para sua produção, seu método e uso
|
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
|
EP1179541B1
(en)
*
|
1999-04-28 |
2004-06-16 |
Board Of Regents, The University Of Texas System |
Compositions and methods for cancer treatment by selectively inhibiting VEGF
|
|
KR20020070285A
(ko)
*
|
1999-11-23 |
2002-09-05 |
메틸진, 인크. |
히스톤 디아세틸라제의 억제제
|
|
CA2423744C
(en)
*
|
2000-09-29 |
2012-04-03 |
Prolifix Limited |
Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
|
|
GB0023983D0
(en)
*
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
EP1335898B1
(en)
*
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
JPWO2002074298A1
(ja)
*
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
MXPA04001253A
(es)
*
|
2001-08-09 |
2004-06-03 |
Ono Pharmaceutical Co |
Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
|
|
US6897220B2
(en)
*
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
NZ533737A
(en)
*
|
2002-01-11 |
2006-02-24 |
Matthias Rath |
A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
|
|
US20050288227A1
(en)
*
|
2002-02-15 |
2005-12-29 |
Marks Paul A |
Use of thioredoxin measurements for diagnostics and treatments
|
|
JP2005525345A
(ja)
*
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Ｔｒｘ媒介性疾患を処置する方法
|
|
WO2003075839A2
(en)
*
|
2002-03-04 |
2003-09-18 |
Aton Pharma, Inc. |
Methods of inducing terminal differentiation
|
|
US7148257B2
(en)
*
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
US20040132825A1
(en)
*
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
|
US20070060614A1
(en)
*
|
2002-03-04 |
2007-03-15 |
Bacopoulos Nicholas G |
Methods of treating cancer with hdac inhibitors
|
|
WO2003087066A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Sk Chemicals, Co., Ltd. |
α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
|
|
CN100566711C
(zh)
*
|
2002-04-15 |
2009-12-09 |
斯隆-凯特林癌症研究院 |
治疗癌症的化合物及其用途
|
|
US8883148B2
(en)
*
|
2002-04-26 |
2014-11-11 |
Asan Laboratories Company (Cayman), Limited |
Prevention of joint destruction
|
|
US20080004311A1
(en)
*
|
2002-11-12 |
2008-01-03 |
Alcon, Inc. |
Histone deacetylase inhibitors for treating degenerative diseases of the eye
|
|
US20050222013A1
(en)
*
|
2003-01-16 |
2005-10-06 |
Georgetown University |
Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
|
|
CA2518318A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US20040220242A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Leland Shapiro |
Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
|
|
EP1491188A1
(en)
*
|
2003-06-25 |
2004-12-29 |
G2M Cancer Drugs AG |
Topical use of valproic acid for the prevention or treatment of skin disorders
|
|
KR100924737B1
(ko)
*
|
2003-08-26 |
2009-11-04 |
슬로안-케테링인스티튜트퍼캔서리서치 |
Ｈｄａｃ 억제제를 이용한 암의 치료 방법
|
|
EP1689445B1
(de)
*
|
2003-11-14 |
2015-02-25 |
Per Sonne Holm |
Neue verwendung von adenoviren und dafür codierende nukleinsäuren
|
|
EP1689446B1
(de)
*
|
2003-11-14 |
2015-01-07 |
Per Sonne Holm |
Neue adenoviren, dafür codierende nukleinsäuren und deren verwendung
|
|
GB0401876D0
(en)
*
|
2004-01-28 |
2004-03-03 |
Vereniging Het Nl Kanker I |
New use for cancer antigen
|
|
ATE437370T1
(de)
*
|
2004-02-27 |
2009-08-15 |
Us Gov Health & Human Serv |
Pharmakodynamische tests mit durchflusszytometrie
|
|
ES2308065T3
(es)
*
|
2004-04-30 |
2008-12-01 |
Topotarget Germany Ag |
Formulacion que comprende un inhibidor de histona desacetilasa, que exhibe una liberacion bifasica.
|
|
JPWO2006014024A1
(ja)
*
|
2004-08-06 |
2008-05-01 |
小野薬品工業株式会社 |
精神神経系疾患治療剤
|
|
KR20070057822A
(ko)
*
|
2004-08-09 |
2007-06-07 |
아스텔라스세이야쿠 가부시키가이샤 |
히스톤 디아세틸라제 (ｈｄａｃ) 억제제 활성을 갖는히드록시아미드 화합물
|
|
WO2006060382A2
(en)
*
|
2004-11-30 |
2006-06-08 |
Trustees Of The University Of Pennsylvania |
Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
|
|
EP1830864A2
(de)
*
|
2004-12-31 |
2007-09-12 |
Per Sonne Holm |
E1 -minus adenoviren und deren verwendung
|
|
MX2007008781A
(es)
*
|
2005-01-21 |
2007-09-11 |
Astex Therapeutics Ltd |
Compuestos farmaceuticos.
|
|
NZ589276A
(en)
*
|
2005-02-03 |
2012-06-29 |
Topotarget Uk Ltd |
Combination therapies using hdac inhibitors and erlotinib (tarceva)
|
|
US20060229237A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Yih-Lin Chung |
Treatment of gastrointestinal distress
|
|
GB0509225D0
(en)
*
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
|
CN101189003B
(zh)
*
|
2005-05-13 |
2012-02-08 |
托波塔吉特英国有限公司 |
Hdac抑制剂的药物制剂
|
|
EP1743654A1
(en)
*
|
2005-07-15 |
2007-01-17 |
TopoTarget Germany AG |
Use of inhibitors of histone deacetylases in combination with NSAID for the therapy of cancer and/or inflammatory diseases
|
|
US20080292616A1
(en)
*
|
2005-08-19 |
2008-11-27 |
Government Of The United Of America, Represented By The Secretary, Department Of Health And.... |
Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
|
|
KR20080042170A
(ko)
*
|
2005-09-07 |
2008-05-14 |
플렉시콘, 인코퍼레이티드 |
Ｐｐａｒ 활성 화합물
|
|
JP5377968B2
(ja)
*
|
2005-11-10 |
2013-12-25 |
トポターゲット ユーケー リミテッド |
癌治療のために単独で用いるまたは化学療法薬と併用するヒストンデアセチラーゼ（ｈｄａｃ）阻害剤
|
|
US8445198B2
(en)
*
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
MX2008010799A
(es)
*
|
2006-02-22 |
2008-11-06 |
4Sc Ag |
Indolopiridinas como moduladores de quinesina eg5.
|
|
EP3862354A1
(en)
*
|
2006-02-22 |
2021-08-11 |
4Sc Ag |
Indolopyridines as eg5 kinesin modulators
|
|
EP1839656A1
(en)
*
|
2006-03-31 |
2007-10-03 |
TopoTarget Germany AG |
Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
|
|
WO2007129062A1
(en)
*
|
2006-05-08 |
2007-11-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
EP2040731A4
(en)
*
|
2006-06-09 |
2010-05-19 |
Merrion Res Iii Ltd |
SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
|
|
US8338482B2
(en)
*
|
2006-07-20 |
2012-12-25 |
Wisconsin Alumni Research Foundation |
Modulating notch1 signaling pathway for treating neuroendocrine tumors
|
|
WO2008058287A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Syndax Pharmaceuticals, Inc. |
COMBINATION OF ERα+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
|
|
US8796330B2
(en)
*
|
2006-12-19 |
2014-08-05 |
Methylgene Inc. |
Inhibitors of histone deacetylase and prodrugs thereof
|
|
WO2008094319A2
(en)
*
|
2007-02-01 |
2008-08-07 |
The Board Of Regents Of The University Of Texas Sytem |
Methods and compositions of trail-death receptor agonists/activators
|
|
WO2008101121A2
(en)
*
|
2007-02-14 |
2008-08-21 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions relating to promoter regulation by muc1 and klf proteins
|
|
WO2008136838A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Trustees Of Dartmouth College |
Novel amide derivatives of cddo and methods of use thereof
|
|
EP2167090A4
(en)
*
|
2007-06-06 |
2010-08-25 |
Univ Maryland |
HDAC INHIBITORS AND HORMONE TREATMENT MEDICAMENTS
|
|
WO2009146034A2
(en)
*
|
2008-03-31 |
2009-12-03 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
|
US20090270497A1
(en)
*
|
2008-04-24 |
2009-10-29 |
Pharmacyclics, Inc. |
Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
|
|
WO2009137649A2
(en)
*
|
2008-05-07 |
2009-11-12 |
The Trustees Of The University Of Pennsylvania |
Methods for treating thyroid cancer
|